Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGC20-1531 in Migraine Patients
NCT00888680Phase 2Withdrawn
- Sponsor
- Boston Scientific Corporation
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of BGC20-1531 in migraine, sponsored by Boston Scientific Corporation. Status: withdrawn.
02
Drugs
BGC20-1531
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00888680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888680.